Skip to main content
. 2020 Jan 23;105(6):1814–1826. doi: 10.1210/clinem/dgz256

Table 1.

Clinical characteristics of women with oligo-amenorrhea (OA), hirsutism (H), and PCOS (OA + H) at ages 31 and 46 compared with women without PCOS symptoms.

Character Age Ctrl at age 31 N = 1382–2182 at age 46 N = 1412–1613 OA at age 31 N = 214–329 at age 46 N = 211–247 H at age 31 N = 211–323 at age 46 N = 216–238 PCOS at age 31 N = 74–125 at age 46 N = 75–86
BMI (kg/m2) 31 23.8 ± 4.3 24.8 ± 5.3** 24.3 ± 4.6 27.3 ± 6.9***
46 26.4 ± 5.3 27.3 ± 5.7* 27.3 ± 6.0** 29.1 ± 6.0***
≥25kg/m 2 ≥30 ≥25 ≥30 ≥25 ≥30 ≥25 ≥30
BMI (%) 31 21.8 8.1 26.1** 12.5** 20.2 12.1 28.1*** 25.6***
46 31.9 21.8 32.0 26.6 38.2 22.7 24.3*** 43.3***
BMI change (kg/m2) 14–31 4.4 ± 3.5 5.2 ± 4.4** 4.4 ± 3.5 6.3 ± 4.9***
31–46 2.8 ± 3.2 2.7 ± 3.6 2.9 ± 3.3 2.0 ± 4.1*
Waist (cm) 31 78.8 ± 11.8 80.9 ± 13.1** 79.1 ± 11.8 88.0 ± 17.5***
46 86.2 ± 13.1 88.9 ± 13.8** 90.0 ± 14.1* 93.3 ± 15.2**
Testosterone (nmol/L) 31 0.98 (0.75;1.23) 1.11 (0.85;1.45)*** 1.04 (0.82;1.38)** 1.40 (1.17;1.80)***
46 0.83 (0.63;1.05) 0.81 (0.65;1.04) 0.87 (0.69;1.16)** 0.93 (0.72;1.17)*
FAI 31 2.10 (1.49;2.97) 2.79 (1.77;4.11)*** 2.50 (1.64;3.71)*** 4.38 (2.75;6.79)***
46 1.51 (1.06;2.15) 1.62 (1.22;2.32)** 1.70 (1.21;2.54)** 1.89 (1.41;2.51)***
Age at menarche 12.9 ± 1.26 13.2 ± 1.51** 12.9 ± 1.34 12.4 ± 1.39
CHC use (%) 46 4.1 3.6 2.5 4.8
0 ≥1 0 ≥1 0 ≥1 0 ≥1
Parity (%) 31 29.3 70.3 26.6 73.4 32.5 67.5 36.8 63.2
46 16.7 83.3 12.3 87.7 21.1 78.9 11.9 88.1
Infertility (%) 31 15.0 21.2** 15.2 42.6***
46 16.7 23.0* 21.9 37.0***
≦9 9–12 ≥12 ≦9 9–12 ≥12 ≦9 9–12 ≥12 ≦9 9–12 ≥12
Education (years,%) 31 1.4 46.3 52.3 1.8 41.4 56.7 2.8 57.3 39.9*** 3.2 47.6 49.2
46 1.7 55.7 42.6 2.0 50.6 47.4 2.9 62.8 34.3* 4.7 54.7 40.7
Marital status (%) 31 77.7 76.0 69.4** 75.0
46 77.7 76.1 74.3 82.6
Smoking (regular, %) 31 25.0 21.6 27.3 26.6
46 18.4 11.7* 19.4 23.3
Alcohol consumption (g/day) 31 2.20 (0.60;5.90) 1.70 (0.50;4.80)** 1.95 (0.60;5.50) 2.10 (0.65;6.55)
46 2.90 (0.57;8.51) 2.10 (0.24;6.28)* 2.27 (0.49;7.57) 2.21 (0.11;9.24)
Depressive symptoms (%) 31 15.6 17.2 22.9** 24.0*
46 23.4 25.8 34.5*** 33.7*
Anxiety symptoms (%) 31 8.2 7.6 16.1*** 16.1**
46 8.3 7.7 14.8** 12.8

Abbreviations: FAI, free androgen index, CHC combined hormonal contraceptives. The data are presented as mean ± SD or median with (25% lower quartile and 75% upper quartile). ***P < .001, **P < 0.01, and *P < .05 compared with controls. The differences between the controls and different PCOS symptom groups were analyzed using Student’s t-test or Mann–Whitney U test when appropriate with the continuous variables and the differences of prevalence in women with PCOS symptoms compared to controls were analyzed using Pearson chi-square test. Number of subjects for each measurement may vary due to data availability. The missing measurement data of weight and height were displaced with by self-report of the follows proportion at age 31 34.1% and at age 46 14,4%.